Hematology - European Medical Journal

This site is intended for healthcare professionals

Continue

Hematology

Filter
6 Mins
23 Jun 2020

The Role of Next-Generation Sequencing and Reduced Time to Diagnosis In Haematological Diseases: Status Quo and Prospective Overview of Promising Molecular Testing Approaches

This review centres on the impact next-generation sequencing (NGS) can have on the current management of haemato-oncological diseases…
15 Jun 2020

Convalescent Plasma Transfusion Therapy for COVID-19 Shows Promise

CONVALESCENT plasma transfusion for the treatment of severe COVID-19 is currently being trialled in the UK
15 Jun 2020

Will Selective CAR T Cells for Acute Myeloid Leukaemia Replace Chemotherapy?

IMMUNOTHERAPY for acute myeloid leukaemia (AML) has shown promise in recent years, and now results from a study that demonstrated improved selectivity
10 Mins
13 May 2020

Beyond Clinical Trials in B-Cell Malignancies: What Real-World Experience Tells Us

The Kite, a Gilead company, symposium “Beyond Clinical Trials in B-Cell Malignancies: What Real-World Experience Tells Us” took place as part of the 24th…
10 Mins
13 May 2020

CAR-T: From Bed to Bench and Back Again

The Kite, a Gilead Company, symposium “CAR-T: From bed to bench and back again” took place during the 2019 meeting of the International Conference…
Antibody Therapies for Patients With Diffuse Large B-cell Lymphoma: What Does the Future Hold?
12 Mins
5 May 2020

Antibody Therapies for Patients With Diffuse Large B-cell Lymphoma: What Does the Future Hold?

Prof Sehn opened the symposium with an overview of diffuse large B-cell lymphoma (DLBCL) focussing on key milestones in treatment developments…
Managing Follicular Lymphoma
11 Mins
28 Apr 2020

Practical Insights into Managing Follicular Lymphoma: What’s Best for Patients?

The first case focussed on a 56-year-old female economist, who presented with abdominal discomfort that led to a CT scan evaluation where lymph node…
New Drug Approved for Multiple Myeloma Treatment
17 Mar 2020

New Drug Approved for Multiple Myeloma Treatment

ISATUXIMAB (Sarclisa®, Sanofi), an anti-CD38 monoclonal antibody, has received approval by the U.S. Food and Drug Administration…
We’ve noticed you’re accessing
from North/South America.